Author

C. Press

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:bacteria (other)· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:multiome· 1 Assay:proteomics· 1

Frequent Co-Authors

A. B. Lanne· 1 shared A. Feula· 1 shared A. Gerhardt· 1 shared A. Goff· 1 shared A. Yoshizawa· 1 shared C. B. Fox· 1 shared C. Casper· 1 shared C. J. Paddon· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. B. Lanne

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability

E. A. Voigt, A. Gerhardt, D. Hanson, P. Battisti, S. Reed, J. Singh, R. Mohamath, M. F. Jennewein, J. Bakken, S. Beaver, C. Press, P. Soon-Shiong, C. J. Paddon, C. B. Fox, C. Casper

This paper develops a self-amplifying RNA vaccine against SARS-CoV-2 with room-temperature stability and strong immune responses in preclinical studies.

bioRxiv · Mar 22, 2022Immunology

Bacterial competition systems share a domain required for inner membrane transport of the nuclease bacteriocin pyocin G

I. Atanaskovic, C. Sharp, C. Press, R. Kaminska, C. Kleanthous

This study identifies a conserved domain essential for inner membrane translocation of nucleases in bacterial competition systems, using PyoG as a model.

bioRxiv · Nov 17, 2021 · PreprintMicrobiology

Azetidines kill Mycobacterium tuberculosis without detectable resistance by blocking mycolate assembly.

A. B. Lanne, Y. Cui, E. Browne, P. G. E. Craven, N. J. Cundy, N. J. Coltman, K. Dale, A. Feula, J. Frampton, A. Goff, M. A. Hama Salih, X. Lang, X. Li, C. W. Moon, M. Morton, , L. J. Alderwick

The paper identifies azetidine derivatives that kill Mycobacterium tuberculosis without resistance by inhibiting mycolate assembly, showing a novel mode of action and favorable pharmacological profiles.

bioRxiv · Sep 3, 2020 · PreprintMicrobiology

High-Accuracy Multiplexed SARS-CoV-2 Antibody Assay with Avidity and Saliva Capability on a Nano-Plasmonic Platform

T. Liu, J. Hsiung, S. Zhao, J. Kost, D. Sreedhar, K. Olson, D. Keare, J. Roche, C. V. Hanson, C. Press, J. Boggs, J. P. Rodriguez-Soto, J. G. Montoya, M. Tang, H. Dai

This paper develops a high-accuracy multiplexed SARS-CoV-2 antibody assay using a nano-plasmonic platform, showing high specificity and sensitivity in serum and saliva samples.

bioRxiv · Jun 16, 2020 · PreprintBiochemistry